|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/06 | (2006.01) |
| C07D 471/10 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61P 31/14 | (2006.01) |
| (11) | Number of the document | 3204375 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15782033.3 |
| Date of filing the European patent application | 2015-10-06 | |
| (97) | Date of publication of the European application | 2017-08-16 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-13 |
| (46) | Date of publication of the claims translation | 2019-05-10 |
| (86) | Number | PCT/GB2015/052920 |
| Date | 2015-10-06 |
| (87) | Number | WO 2016/055780 |
| Date | 2016-04-14 |
| (30) | Number | Date | Country code |
| 201417707 | 2014-10-07 | GB |
| (72) |
COCKERILL, Stuart, GB
MATHEWS, Neil, GB
WARD, Simon, GB
LUNN, Graham, GB
PARADOWSKI, Michael, GB
GASCON SIMORTE, Jose Miguel, GB
|
| (73) |
Pfizer Inc.,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Spiro-indolinai, skirti respiracinio sincitinio viruso (RSV) infekcijos gydymui ir profilaktikai |
| SPIRO-INDOLINES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION (RSV) |
| Payment date | Validity (years) | Amount | |
| 2025-09-16 | 11 | 289.00 EUR |
| 2026-10-06 |